Identification of a novel fusion gene <i>MLL‐MAML2</i> in secondary acute myelogenous leukemia and myelodysplastic syndrome with inv(11)(q21q23)Noriko Nemoto, Toshiro Nagasawa, Kazumi Suzukawa et al.|Genes Chromosomes and Cancer|2007Cited by 43
Measurement of Proteasome Activity in Peripheral Blood Mononuclear Cells as an Indicator of Susceptibility to Bortezomib-Induced Severe Neurological Adverse Events in Patients with Multiple MyelomaYukiko Cho, Atsushi Shinagawa, Daisuke Kudo et al.|Acta Haematologica|2015Cited by 1
Predicting bortezomib-related severe neurologic adverse events by measuring proteasome activity in PBMCs.Yukiko Cho, Mitsuo Hori, Yasushi Okoshi et al.|Journal of Clinical Oncology|2012Cited by 0